We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+12.07%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$101M
AUM Growth
+$7.48M
Cap. Flow
+$699K
Cap. Flow %
0.69%
Top 10 Hldgs %
86.04%
Holding
24
New
2
Increased
–
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
CRON
Cronos Group
CRON
+$9.35M
2
TSLA icon
Tesla
TSLA
+$1.65M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$6.62M
2
CBM
Cambrex Corporation
CBM
+$1.44M
3
ADVM
Adverum Biotechnologies
ADVM
+$625K
4
CPIX icon
Cumberland Pharmaceuticals
CPIX
+$585K
5
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$468K

Sector Composition

Rank Sector Weight
1 Healthcare 61.28%
2 Consumer Discretionary 32.88%
3 Technology 5.84%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
1
Amazon
AMZN
$2.48T
$28.4M 28%
392,540
– –
EGRX
2
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$25.1M 24.71%
475,755
– –
CRON
3
Cronos Group
CRON
$1.06B
$7.48M 7.37%
+1,111,444
New +$9.35M
JNP
4
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$4.33M 4.27%
426,903
– –
PETQ
5
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3.96M 3.9%
148,855
-20,000
-12% -$468K
ATRS
6
DELISTED
Antares Pharma, Inc.
ATRS
$3.9M 3.84%
1,770,524
-107,799
-6% -$243K
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.85M 3.79%
270,775
– –
MSFT icon
8
Microsoft
MSFT
$2.92T
$3.79M 3.73%
41,500
– –
BSTC
9
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.27M 3.22%
73,649
– –
BABA icon
10
Alibaba
BABA
$276B
$3.26M 3.21%
17,750
– –
AVDL
11
DELISTED
Avadel Pharmaceuticals
AVDL
$3.24M 3.19%
444,439
– –
LGND icon
12
Ligand Pharmaceuticals
LGND
$5.94B
$2.21M 2.18%
21,482
– –
MU icon
13
Micron Technology
MU
$927B
$2.14M 2.11%
41,000
– –
TSLA icon
14
Tesla
TSLA
$1.21T
$1.33M 1.31%
+75,000
New +$1.65M
CBM
15
DELISTED
Cambrex Corporation
CBM
$1.23M 1.21%
23,519
-27,000
-53% -$1.44M
CPIX icon
16
Cumberland Pharmaceuticals
CPIX
$102M
$1.2M 1.18%
178,942
-84,939
-32% -$585K
NVLN
17
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.11M 1.09%
315,979
– –
ALIM
18
DELISTED
Alimera Sciences
ALIM
$717K 0.71%
46,400
-18,000
-28% -$319K
ARLZ
19
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$434K 0.43%
289,664
– –
BBBY
20
Bed Bath & Beyond
BBBY
$503M
$363K 0.36%
13,310
– –
SNOA icon
21
Sonoma Pharmaceuticals
SNOA
$5.46M
$151K 0.15%
228
– –
TLGT
22
DELISTED
Teligent, Inc
TLGT
$46K 0.05%
1,382
– –
ADVM
23
DELISTED
Adverum Biotechnologies
ADVM
– –
-17,865
Closed -$625K
META icon
24
Meta Platforms (Facebook)
META
$1.51T
– –
-37,500
Closed -$6.62M

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, JW Asset Management held 24 positions worth $101M, up 8% from $94M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

JW Asset Management's Q1 2018 filing shows 2 new, 5 reduced and 2 closed positions. Its largest new stake was Cronos Group: 1,111,444 shares worth $7.48M. The largest sale was Meta Platforms (Facebook), an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JW Asset Management's largest Q1 2018 buy was Cronos Group: 1,111,444 shares worth $7.48M.
  • JW Asset Management's biggest Q1 2018 reduction was Cambrex Corporation, cutting an estimated $1.44M.
  • JW Asset Management fully exited Meta Platforms (Facebook) in Q1 2018, selling an estimated $6.62M.
  • JW Asset Management's ten largest holdings make up 86% of its $101M portfolio in Q1 2018.
  • JW Asset Management opened 2 new positions and closed 2 in Q1 2018.
  • JW Asset Management's portfolio value rose 8% quarter-over-quarter to $101M.

Based on JW Asset Management's 13F filing for Q1 2018, filed 11 May 2018.